Internists Encouraged By Rule Requiring Transparency in Drug Pricing in Television Ads

Statement attributable to:
Robert McLean, MD, F바카라 사리트
President, American College of Physicians

Washington, DC (May 9, 2019) —The American College of Physicians (바카라 사리트) is encouraged by the final rule announced by the Trump Administration to require pharmaceutical manufacturers to disclose the cost of drugs in television advertisements. 바카라 사리트 believes that this is a promising step in improving transparency in prescription drug pricing. Prescription medications are only as effective as a patient’s ability to access and adhere to treatment as prescribed.

바카라 사리트 outlined its support for increasing transparency in the pricing, cost, and comparative value of all pharmaceutical products in our 2016 policy paper, . We also support broad efforts by federal regulators to ensure that information about a drug's effectiveness and safety, and about alternative treatments, is clearly disclosed to patients.

바카라 사리트 looks forward to continuing to work with Congress and the administration in implementing policies that promote transparency in drug pricing, supporting extensive research efforts into innovative and value-based systems, and improving access to getting prescription drugs to the market and into the hands of the patients who need them most.

***

About the American College of Physicians
The American College of Physicians is the largest medical specialty organization in the United States with members in more than 145 countries worldwide. 바카라 사리트 membership includes 154,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. Follow 바카라 사리트 on , , and .

Contact: Julie Hirschhorn, (202) 261-4523, jhirschhorn@acponline.org